TSC2 — Tuberous Sclerosis Complex 2
Introduction
Tsc2 — Tuberous Sclerosis Complex 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Tuberous Sclerosis Complex 2 (TSC2) encodes the protein tuberin, a crucial tumor suppressor protein that forms a functional complex with TSC1 (hamartin). This complex is a master regulator of the [mTOR](/entities/mtor) (mechanistic target of rapamycin) signaling pathway, controlling cell growth, proliferation, and metabolism. Mutations in TSC2 cause tuberous sclerosis complex, a genetic disorder characterized by benign tumors throughout the body and significant neurological manifestations including epilepsy, intellectual disability, and autism. [@tee2002]
<div class="infobox infobox-gene"> [@dabora2001]
| Property | Value | [@crino2016]
|----------|-------| [@franz2013]
| Gene Symbol | TSC2 | [@ehninger2008]
| Full Name | Tuberous Sclerosis Complex 2 | [@mcmahon2012]
| Chromosomal Location | 16p13.3 | [@inoki2005]
| NCBI Gene ID | 7249 |
| Ensembl ID | ENSG00000103197 |
| OMIM ID | 191221 |
| UniProt ID | P49815 |
| Protein Name | Tuberin |
| Molecular Weight | ~200 kDa |
</div>
Normal Function
Tuberin Protein Structure
...TSC2 — Tuberous Sclerosis Complex 2
Introduction
Tsc2 — Tuberous Sclerosis Complex 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Tuberous Sclerosis Complex 2 (TSC2) encodes the protein tuberin, a crucial tumor suppressor protein that forms a functional complex with TSC1 (hamartin). This complex is a master regulator of the [mTOR](/entities/mtor) (mechanistic target of rapamycin) signaling pathway, controlling cell growth, proliferation, and metabolism. Mutations in TSC2 cause tuberous sclerosis complex, a genetic disorder characterized by benign tumors throughout the body and significant neurological manifestations including epilepsy, intellectual disability, and autism. [@tee2002]
<div class="infobox infobox-gene"> [@dabora2001]
| Property | Value | [@crino2016]
|----------|-------| [@franz2013]
| Gene Symbol | TSC2 | [@ehninger2008]
| Full Name | Tuberous Sclerosis Complex 2 | [@mcmahon2012]
| Chromosomal Location | 16p13.3 | [@inoki2005]
| NCBI Gene ID | 7249 |
| Ensembl ID | ENSG00000103197 |
| OMIM ID | 191221 |
| UniProt ID | P49815 |
| Protein Name | Tuberin |
| Molecular Weight | ~200 kDa |
</div>
Normal Function
Tuberin Protein Structure
Tuberin is a 1,807 amino acid protein containing several functional domains including a GAP (GTPase-activating protein) domain that specifically targets the small GTPase Rheb (Ras homolog enriched in brain)<sup>[1]</sup>. The TSC1-TSC2 heterodimer localizes primarily to the cytoplasm and intracellular membranes, where it senses cellular energy status and growth factor signals.
Regulation of mTORC1 Signaling
The TSC1-TSC2 complex serves as the primary negative regulator of mTORC1 (mechanistic target of rapamycin complex 1), a central kinase complex that controls protein synthesis, cell growth, and metabolism:
- Inhibition of Rheb: The GAP activity of TSC2 converts active GTP-bound Rheb to inactive GDP-bound Rheb, thereby inhibiting mTORC1 activation<sup>[2]</sup>
- Energy sensing: TSC2 senses cellular energy (AMP/ATP ratio) through AMPK activation, inhibiting mTORC1 during energy deprivation
- Growth factor regulation: PI3K/Akt signaling phosphorylates and inhibits TSC2, allowing mTORC1 activation in response to growth factors
Role in Cellular Homeostasis
Beyond [mTOR](/mechanisms/mtor-signaling-pathway) regulation, TSC2 participates in:
- Cell cycle control: TSC2 loss leads to uncontrolled cell proliferation
- [Autophagy](/entities/autophagy) regulation: Proper TSC2 function is essential for autophagy induction under stress conditions
- DNA damage response: TSC2 interacts with DNA repair pathways
- Synaptic plasticity: TSC2 is expressed in [neurons](/entities/neurons) and regulates synaptic function
Disease Associations
Tuberous Sclerosis Complex (TSC)
Approximately 70-80% of TSC cases are caused by mutations in TSC2, making it the more common genetic cause of the disorder<sup>[3]</sup>. TSC2 mutations typically cause more severe disease compared to TSC1 mutations:
- Renal manifestations: More severe renal angiomyolipomas and polycystic kidney disease
- Neurological complications: Higher frequency of infantile spasms and refractory epilepsy
- Brain tumors: Subependymal giant cell astrocytomas (SEGAs)
- Skin lesions: More extensive angiofibromas and Shagreen patches
Neurological and Neurodegenerative Aspects
- Epilepsy: Occurs in 80-90% of TSC2 patients, often severe and refractory
- Cortical tubers: The number and location of cortical tubers correlate with epilepsy severity and cognitive outcomes
- Autism spectrum disorder: Affects up to 50% of individuals with TSC
- Intellectual disability: Variable severity, correlates with early seizure control
- Neurodegeneration risk: Growing evidence suggests increased neurodegenerative risk in aging TSC patients
mTORopathies
TSC2 is part of a broader category of "mTORopathies" - neurological disorders characterized by mTOR pathway dysregulation<sup>[4]</sup>. These include:
- Focal cortical dysplasia
- Hemimegalencephaly
- Ganglioglioma
- Pretectal nodular heterotopia
Therapeutic Implications
mTOR inhibitors (everolimus, sirolimus) are first-line treatments for TSC-related complications:
- Reduction in SEGA size
- Decreased seizure frequency
- Shrinkage of renal angiomyolipomas
- Improvement in facial angiofibromas
Expression Patterns
Tuberin is ubiquitously expressed with high levels in:
- Brain (cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum)
- Kidney (renal tubular cells)
- Heart
- Lung
- Adrenal gland
- Testis
In neurons, TSC2 is localized to synapses and regulates dendritic spine morphology and synaptic plasticity.
Background
The study of Tsc2 — Tuberous Sclerosis Complex 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- Tuberous Sclerosis Complex
- [mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway)
- TSC1 — Hamartin
- [Epilepsy](/diseases/epilepsy)
- [Autophagy](/mechanisms/autophagy-lysosome-neurodegeneration)
External Links
- [NCBI Gene: TSC2](https://www.ncbi.nlm.nih.gov/gene/7249)
- [UniProt: P49815](https://www.uniprot.org/uniprot/P49815)
- [OMIM: 191221](https://www.omim.org/entry/191221)
- [Tuberous Sclerosis Alliance](https://www.tsalliance.org/)
- [Ensembl: ENSG00000103197](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103197)
- [Allen Brain Atlas: TSC2](https://human.brain-map.org/microarray/search/show?search_term=TSC2)
Brain Atlas Resources
Allen Human Brain Atlas
- [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=TSC2): Interactive gene expression data across the adult human brain
Allen Cell Type Atlas
- [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Single-cell transcriptomics data for neuronal and glial cell types
BrainSpan Transcriptome Atlas
- [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental gene expression data from prenatal to adult brain
Mouse Brain Atlas
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive gene expression maps in the mouse brain
Links verified: 2026-03-16References
[Unknown, The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75(2):1305-1315 (1993)](https://pubmed.ncbi.nlm.nih.gov/8269512/)
[Tee AR, Fingar DC, Manning BD, et al, Tuberous sclerosis complex-1 and -2 gene products function together to inhibit and stimulate mTOR (2002)](https://pubmed.ncbi.nlm.nih.gov/12007410/)
[Dabora SL, Jozwiak S, Franz DN, et al, Mutational analysis in a cohort of 224 tuberous sclerosis patients (2001)](https://pubmed.ncbi.nlm.nih.gov/11112665/)
[Crino PB, The mTOR signalling cascade: paving new roads to cure neurological disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27230639/)
[Franz DN, Belousova E, Sparagana S, et al, Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the EXIST-1 trial (2013)](https://pubmed.ncbi.nlm.nih.gov/23810380/)
[Ehninger D, Han S, Shilyansky C, et al, Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis (2008)](https://pubmed.ncbi.nlm.nih.gov/18568033/)
[McMahon J, McDowell S, Egelhoff J, et al, Tuberous sclerosis associated neuropsychiatric disorders (TAND) (2012)](https://pubmed.ncbi.nlm.nih.gov/23280791/)
[Inoki K, Corradetti MN, Guan KL, TSC2: a core component of the nutrient/energy-responsive complex that integrates growth factor and nutrient signals (2005)](https://pubmed.ncbi.nlm.nih.gov/15917655/)Pathway Context
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving TSC2 — Tuberous Sclerosis Complex 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)